Investing
Top Analyst Upgrades and Downgrades: Coeur Mining, Laredo Petroleum, Marathon Oil, Nike, Statoil and More
Published:
Last Updated:
Despite a pre-Brexit vote rally on Monday, stocks were again higher on Tuesday with the expectation that Britain will remain in the European Union. The reasons seem to differ each and every time, but investors have bought every single market sell-off for years now. Even high stock market valuations are not driving investors away.
24/7 Wall St. reviews dozens of analyst research reports each day of the week. The goal is to find new investing and trading ideas for our readers. Some analyst reports cover stocks to buy, while others feature stocks to sell or avoid.
These are the top analyst upgrades, downgrades and initiations seen on Tuesday morning:
Coeur Mining Inc. (NYSE: CDE) was started with a Sector Perform rating and was given a $9 price target (versus a $9.64 prior close) at RBC Capital Markets. It has a consensus analyst price target of $8.28 and a 52-week trading range of $1.62 to $9.78 (and that high was yesterday).
Laredo Petroleum Inc. (NYSE: LPI) was started with an Overweight rating and given a $14 price target (versus an $11.38 close) at Barclays. It has a consensus target price of $12.09 and a 52-week range of $3.90 to $14.39.
Marathon Oil Corp. (NYSE: MRO) was raised to Overweight from Equal Weight with a $21 price target (versus a $14.48 close) at Morgan Stanley. Credit Suisse already had an Outperform rating, but the firm raised its target to $18.50 from $18.00. The consensus price target is $16.04, and the 52-week range is $6.52 to $27.77.
Nike Inc. (NYSE: NKE) was maintained as Buy at Jefferies, but the price target was cut to $67 from $74. The firm said that it expects in-line results when Nike reports earnings next week, but the focus should be on the comments and an update to the 2017 outlook. The consensus price target is $70.46, and the 52-week range is $47.25 to $68.19.
Statoil ASA (NYSE: STO) was downgraded to Sell from Hold at Deutsche Bank. Shares closed at $16.64, and the consensus price target is $16.43. The 52-week range is $10.89 to $18.61.
You can follow @JonOgg if you wish to get analyst upgrades and downgrades directly on your Twitter feed.
Other top analyst upgrades and downgrades were seen in the following:
Alarm.com Holdings Inc. (NASDAQ: ALRM) was downgraded to In-Line from Outperform with a $24.50 price target (versus a $25.04 close) at Imperial Capital.
BATS Global Markets (BATS) was started with an Underperform rating and was given a $23 price target (versus a $27.47 close) at RBC Capital Markets.
BorgWarner Inc. (NYSE: BWA) was downgraded to Neutral from Buy at Merrill Lynch.
Catalent Inc. (NYSE: CTLT) was raised to Outperform from Market Perform at Wells Fargo.
Charles River Laboratories International Inc. (NYSE: CRL) was started with a Neutral rating and was assigned a target price of $84 at Credit Suisse.
Delek Logistics Partners L.P. (NYSE: DKL) was raised to Buy from Neutral with a $32 price target (versus a $25.90 close) at Goldman Sachs.
Helmerich & Payne Inc. (NYSE: HP) was raised to Overweight from Sector Weight with an $80 price target (versus a $65.63 close) at KeyBanc Capital Markets.
ICON PLC (NASDAQ: ICLR) was started with an Outperform rating and was assigned an $80 price target (versus a $64.95 close) at Credit Suisse. The firm said the valuation reflects challenges rather than its opportunities.
IDEX Corp. (NYSE: IEX) was started with a Neutral rating and was given a fair value estimate of $87 (versus an $85.49 close) at Janney.
Kirby Corp. (NYSE: KEX) was downgraded to Neutral from Outperform with a $60 price target (versus a $69.83 close) at Credit Suisse.
Lear Corp. (NYSE: LEA) was downgraded to Neutral from Buy at Merrill Lynch.
ProLogis Inc. (NYSE: PLD) was downgraded to Hold from Buy with a $50 price target (versus a $49.89 close) at Deutsche Bank.
Summit Therapeutics PLC (NASDAQ: SMMT) was started with a Buy rating and was assigned a fair value estimate of $15 (versus a $7.77 close) at Janney.
Werner Enterprises Inc. (NASDAQ: WERN) was downgraded to Hold from Buy at Deutsche Bank, and it was downgraded to Underperform from Neutral at Merrill Lynch. JPMorgan downgraded Werner to Neutral from Overweight. The stock was indicated down 11% at $22.00 due to weaker earnings.
Monday’s top analyst upgrades and downgrades included Chesapeake Energy, Motorola Solutions, Pfizer, Spirit Air, Symantec, Under Armour, US Foods and over a dozen more.
Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.